RESORBA Medical GmbH
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
RESORBA Medical GmbH - overview
Established
1931
Location
Nuremberg, -, Germany
Primary Industry
Medical Devices & Equipment
About
RESORBA Medical GmbH is a medical technology company specializing in surgical products, including meshes, sutures, and wound care solutions, aimed at enhancing surgical outcomes across various medical fields. Founded in 1931, RESORBA Medical GmbH operates from Nuremberg, Germany, focusing on the development of surgical products. The company was acquired in December 2011 by Advanced Medical Solutions Group plc for EUR 63. 8 million, marking a significant milestone in its operational strategy.
The firm has completed a total of 2 deals, with the most recent deal in December 2011. RESORBA Medical GmbH specializes in a comprehensive range of surgical products designed to meet the unique needs and quality standards of various medical fields. The company's core offerings include advanced surgical meshes, sutures, and wound care solutions that cater to multiple surgical specialties. These products are engineered to facilitate effective healing and improve patient outcomes in both routine and complex surgical procedures.
RESORBA serves diverse clientele, including hospitals, surgical centers, and healthcare professionals across multiple regions, particularly in Germany, the USA, and the Czech Republic. The company’s commitment to innovation ensures that its products are continuously optimized based on feedback from end users, enhancing surgical efficacy and patient safety. RESORBA Medical GmbH generated revenue of EUR 43,887,832. 60 in 2022, with an EBITDA of EUR 9,802,505.
90 for the same year. The company primarily earns revenue through direct sales of its surgical products to healthcare institutions and professionals, engaging in B2B partnerships where hospitals and surgical centers procure products based on specific needs and procedural requirements. Future growth for RESORBA Medical GmbH focuses on expanding its product line and market reach. The company aims to introduce new surgical products designed to cater to emerging medical technologies and practices.
Furthermore, RESORBA plans to penetrate additional markets, targeting expansion into regions with increasing demand for surgical innovations by 2025. The proceeds from the EUR 63. 8 million deal with Advanced Medical Solutions Group plc will support these initiatives, enhancing product development and facilitating entry into new geographical markets.
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Equipment Distributors, Biomaterials
Website
www.resorba.com
Company Stage
Acquired
Total Amount Raised
Subscriber access only
RESORBA Medical GmbH - financials
| Fiscal Year Ended | Dec 31, 2009 | Dec 31, 2010 | Dec 31, 2011 | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 8,185,092.4 | 20,106,574.9 | 20,944,453.5 | - | - | 22,846,579.1 | 23,432,887.7 | 24,451,781 | 28,828,000 | 32,101,000 | 32,388,000 | 30,162,000 | - | - | - |
| % Revenue Growth (YoY) | - | 145.6% | 4.2% | - | - | - | 2.6% | 4.3% | 17.9% | 11.4% | 0.9% | (6.9%) | - | - | - |
| EBITDA (USD) | 2,987,000 | 7,654,342.8 | 6,391,264.5 | - | - | 6,837,407.2 | 5,940,265 | (6,452,880.8) | 14,227,697.9 | (7,611,246.9) | 560,788.1 | 4,872,716.4 | - | - | - |
| Operating Income (USD) | 1,866,691.9 | 4,990,687.5 | 3,757,886.5 | - | - | 6,413,611.2 | 5,509,582.9 | (6,970,554.2) | 13,754,422.6 | (8,195,398) | (12,217,170.8) | 4,429,451.8 | - | - | - |
| Operating Margin | 22.8% | 24.8% | 17.9% | - | - | 28.1% | 23.5% | (28.5%) | 47.7% | (25.5%) | (37.7%) | 14.7% | - | - | - |
| % EBITDA Margin | 36.5% | 38.1% | 30.5% | - | - | 29.9% | 25.4% | (26.4%) | 49.4% | (23.7%) | 1.7% | 16.2% | - | - | - |
| NET Income (USD) | 238,583.1 | 882,682.8 | 176,687.4 | - | - | (6,398,070.8) | (5,480,842.9) | (3,477,548.9) | 6,866,155.1 | (4,090,665.2) | (6,099,809.7) | (4,412,548.3) | - | - | - |
| % Net Margin | 2.9% | 4.4% | 0.8% | - | - | (28.0%) | (23.4%) | (14.2%) | 23.8% | (12.7%) | (18.8%) | (14.6%) | - | - | - |
RESORBA Medical GmbH - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Trade Sale | Completed | RESORBA Medical GmbH | - | ||||||||
| Buyout | Completed | RESORBA Medical GmbH | - |
Displaying 1 - 2 of 2
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.